Download presentation
Presentation is loading. Please wait.
Published byElsa Mäkinen Modified over 5 years ago
1
Alternate-Day Micafungin Antifungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pharmacokinetic Study Parinda A. Mehta, Alexander A. Vinks, Alexandra Filipovich, Jack Bleesing, Sonata Jodele, Michael B. Jordan, Rebecca Marsh, Richard Tarin, Stephanie Edwards, Deborah Fearing, Julia Lawrence, Stella M. Davies Biology of Blood and Marrow Transplantation Volume 16, Issue 10, Pages (October 2010) DOI: /j.bbmt Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions
2
Figure 1 Mean concentration-time profiles of micafungin (3 mg/kg dose) in pediatric HSCT patients (mean data points ± SD). Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.